|
|
Last Modified: 1/1/1998  First Published: 11/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
CPMC-IRB-6850 NCI-P97-0109
|
|
|
|
|
|
|
|
Last Modified: 11/1/2000  First Published: 11/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
OHSU-5231 OCC-HOR-98068-L, NCI-V99-1542, NCT00004043
|
|
|
|
|
|
|
|
Last Modified: 6/1/2002  First Published: 6/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
OHSU-6218 OHSU-HOR-00059-L, NCI-G01-1963, NCT00017576
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
no age specified
|
|
|
|
|
|
|
|
PCI-9304 NCI-V93-0286
|
|
|
|
|
|
|
|
Last Modified: 2/9/2005  First Published: 1/26/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
RPCI-RP-0203 PCI-00-034, NCT00054522
|
|
|
|
|
|
|
|
Last Modified: 8/12/2008  First Published: 6/25/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
CINJ-080404 CINJ-4901, CINJ-NJ3803, CINJ-5111, NCT00118066
|
|
|
|
|
|
|
|
Last Modified: 10/16/2007  First Published: 9/9/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 100
|
|
|
|
NCI
|
|
|
|
OHSU-8451 OHSU-VA-IRB-9451, NCT00182741
|
|
|
|
|
|
|
|
Last Modified: 12/20/2007  First Published: 10/7/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Over 18
|
|
|
|
NCI
|
|
|
|
OHSU-GIM-02007-L OHSU-1104, NCT00238199
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Temporarily closed
|
|
|
|
18 to 90
|
|
|
|
Other
|
|
|
|
PROS0021 95804, NCT00383487, PROS0021, NCT00383487
|
|
|
|
|
|
|
|
Last Modified: 7/23/2008  First Published: 8/28/2007 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Biomarker/Laboratory analysis, Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
NCI
|
|
|
|
RPCI-I-65405 I 65405, NCT00524589
|
|
|
|